Indeed, our data demonstrated that treatment with an ALKi alone decreased CD206+ TAM infiltration and reduced tumor weights in the RNase1-expressing orthotopic HCC model (Fig. 5c–e). Here, RNASE1 is linked to hepatocellular carcinoma.